NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $175.17 -1.88 (-1.06%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$174.18▼$178.0050-Day Range$167.06▼$182.7252-Week Range$142.51▼$183.64Volume3,565 shsAverage Volume7,368 shsMarket Capitalization$450.19 millionAssets Under Management$445.59 millionDividend Yield0.41%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Biotech ETF alerts: Email Address About VanEck Biotech ETF (NASDAQ:BBH)The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More BBH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBH ETF News HeadlinesSeptember 7 at 4:23 AM | seekingalpha.comEmphasize Consistency To Navigate VolatilityAugust 29, 2024 | benzinga.comVanEck Fabless Semiconductor ETF (NASDAQ:SMHX) Quotes, Forecast and News SummarySeptember 7, 2024 | Crypto 101 Media (Ad)Perfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankAugust 15, 2024 | stocknews.com3 Biotech ETFs for a Diversified PortfolioMarch 29, 2024 | benzinga.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 22, 2024 | seekingalpha.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentJanuary 30, 2024 | msn.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioDecember 19, 2023 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127September 7, 2024 | Crypto 101 Media (Ad)Perfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankDecember 9, 2023 | seekingalpha.comBBH: A Solid Way To Play A Comeback In BiotechSee More Headlines Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings27 Fund Statistics Assets Under Management$445.59 million Average Daily Volume$5,780.60 Discount/Premium0.19% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume1 Put Options1 Call Options1 Short Interest5,700 shs Miscellaneous Outstanding Shares2,570,000Beta0.85 Creation Unit50,000 Creation Fee$500.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Ad WealthPressThis P/L chart will make your eyes pop Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.55%0.49%0.52%Other Expenses0.00%0.33%0.49%0.41%0.54%Total Expense0.35%0.71%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.53%-0.33%-0.58%Net Expense0.35%0.61%0.61%0.56%0.59% VanEck Biotech ETF (BBH) Holdings & ExposureTop 10 BBH HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 15.08%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 9.59%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.83%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.60%argenx(NASDAQ:ARGX)Holding Weight: 5.67%IQVIA(NYSE:IQV)Holding Weight: 5.31%ICON Public(NASDAQ:ICLR)Holding Weight: 4.24%Illumina(NASDAQ:ILMN)Holding Weight: 4.20%BeiGene(NASDAQ:BGNE)Holding Weight: 4.10%Biogen(NASDAQ:BIIB)Holding Weight: 3.72%BBH Sector ExposureBBH Industry ExposureFull Holdings Details Similar ETFsInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHVanEck Pharmaceutical ETFNASDAQ:PPHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipTruist Financial CorpBought 100 shares on 8/21/2024Ownership: 0.105%Northwestern Mutual Wealth Management Co.Bought 1,334 shares on 8/16/2024Ownership: 0.946%Boston Research & Management Inc.Sold 370 shares on 8/13/2024Ownership: 0.481%Commonwealth Equity Services LLCSold 200 shares on 7/31/2024Ownership: 1.176%Atlas Capital Advisors LLCBought 5,700 shares on 7/30/2024Ownership: 0.222%View All Institutional Transactions BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $165.31 at the beginning of 2024. Since then, BBH stock has increased by 6.0% and is now trading at $175.17. View the best growth stocks for 2024 here. Who are VanEck Biotech ETF's major shareholders? Top institutional shareholders of VanEck Biotech ETF include Commonwealth Equity Services LLC (1.18%), Northwestern Mutual Wealth Management Co. (0.95%), Consolidated Investment Group LLC (0.63%) and Boston Research & Management Inc. (0.48%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU) and Cidara Therapeutics (CDTX). This page (NASDAQ:BBH) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.